Literature DB >> 9487347

Decreased mechanical efficiency in clinically stable patients with COPD.

E M Baarends1, A M Schols, M A Akkermans, E F Wouters.   

Abstract

BACKGROUND: It has recently been reported that total daily energy expenditure (TDE) is increased in patients with chronic obstructive pulmonary disease (COPD) and it was hypothesised that these patients may have a decreased mechanical efficiency during activities. The purpose of the present study was to measure the mechanical efficiency of submaximal leg exercise, and to characterise patients with a potentially low efficiency in terms of body composition, resting energy expenditure, lung function, and symptom limited exercise performance.
METHODS: Metabolic and ventilatory variables were measured breath by breath during submaximal cycle ergometry exercise performed at 50% of symptom limited achieved maximal load in 33 clinically stable patients with COPD (23 men) with forced expiratory volume in one second (FEV1) of 40 (12)% predicted. Net mechanical efficiency was calculated adjusting for resting energy expenditure (REE).
RESULTS: Median mechanical efficiency was 15.5% and ranged from 8.5% to 22.7%. Patients with an extremely low mechanical efficiency (< 17%, n = 21) demonstrated an increased VO2/VE compared with those with a normal efficiency (median difference 4.7 ml/l, p = 0.005) during submaximal exercise. There was no difference between the groups differentiated by mechanical efficiency in blood gas tensions at rest, airflow obstruction, respiratory muscle strength, hyperinflation at rest, resting energy expenditure or body composition. There was a significant difference in total airways resistance (92% predicted, p = 0.03) between the groups differentiated by mechanical efficiency.
CONCLUSIONS: It is concluded that many patients with severe COPD have decreased mechanical efficiency. Furthermore, based on the results of this study it is hypothesised that an increased oxygen cost of breathing during exercise contributes to the decreased mechanical efficiency.

Entities:  

Mesh:

Year:  1997        PMID: 9487347      PMCID: PMC1758448          DOI: 10.1136/thx.52.11.981

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  19 in total

1.  Maximal respiratory pressures: normal values and relationship to age and sex.

Authors:  L F Black; R E Hyatt
Journal:  Am Rev Respir Dis       Date:  1969-05

2.  Lung function impairment as a guide to exercise limitation in work-related lung disorders.

Authors:  J E Cotes; J Zejda; B King
Journal:  Am Rev Respir Dis       Date:  1988-05

3.  Total daily energy expenditure relative to resting energy expenditure in clinically stable patients with COPD.

Authors:  E M Baarends; A M Schols; K R Westerterp; E F Wouters
Journal:  Thorax       Date:  1997-09       Impact factor: 9.139

4.  Muscle strength, symptom intensity, and exercise capacity in patients with cardiorespiratory disorders.

Authors:  A L Hamilton; K J Killian; E Summers; N L Jones
Journal:  Am J Respir Crit Care Med       Date:  1995-12       Impact factor: 21.405

5.  Metabolic and structural changes in skeletal muscle during hypocaloric dieting.

Authors:  D M Russell; P M Walker; L A Leiter; A A Sima; W K Tanner; D A Mickle; J Whitwell; E B Marliss; K N Jeejeebhoy
Journal:  Am J Clin Nutr       Date:  1984-04       Impact factor: 7.045

6.  Interpretation of clinical exercise testing in respiratory disease.

Authors:  M Younes
Journal:  Clin Chest Med       Date:  1984-03       Impact factor: 2.878

7.  Skeletal muscle adaptation to endurance training in patients with chronic obstructive pulmonary disease.

Authors:  F Maltais; P LeBlanc; C Simard; J Jobin; C Bérubé; J Bruneau; L Carrier; R Belleau
Journal:  Am J Respir Crit Care Med       Date:  1996-08       Impact factor: 21.405

8.  Prevalence and characteristics of nutritional depletion in patients with stable COPD eligible for pulmonary rehabilitation.

Authors:  A M Schols; P B Soeters; A M Dingemans; R Mostert; P J Frantzen; E F Wouters
Journal:  Am Rev Respir Dis       Date:  1993-05

9.  Exercise impairment in chronic obstructive pulmonary disease.

Authors:  J Loke; D A Mahler; S F Man; H P Wiedemann; R A Matthay
Journal:  Clin Chest Med       Date:  1984-03       Impact factor: 2.878

10.  Oxidative capacity of the skeletal muscle and lactic acid kinetics during exercise in normal subjects and in patients with COPD.

Authors:  F Maltais; A A Simard; C Simard; J Jobin; P Desgagnés; P LeBlanc
Journal:  Am J Respir Crit Care Med       Date:  1996-01       Impact factor: 21.405

View more
  10 in total

1.  Quadriceps exercise intolerance in patients with chronic obstructive pulmonary disease: the potential role of altered skeletal muscle mitochondrial respiration.

Authors:  Jayson R Gifford; Joel D Trinity; Gwenael Layec; Ryan S Garten; Song-Young Park; Matthew J Rossman; Steen Larsen; Flemming Dela; Russell S Richardson
Journal:  J Appl Physiol (1985)       Date:  2015-08-13

2.  Determinants of the diminished exercise capacity in patients with chronic obstructive pulmonary disease: looking beyond the lungs.

Authors:  Ryan M Broxterman; Jan Hoff; Peter D Wagner; Russell S Richardson
Journal:  J Physiol       Date:  2020-01-19       Impact factor: 5.182

3.  Polyunsaturated fatty acids improve exercise capacity in chronic obstructive pulmonary disease.

Authors:  R Broekhuizen; E F M Wouters; E C Creutzberg; C A P M Weling-Scheepers; A M W J Schols
Journal:  Thorax       Date:  2005-05       Impact factor: 9.139

4.  Raised CRP levels mark metabolic and functional impairment in advanced COPD.

Authors:  R Broekhuizen; E F M Wouters; E C Creutzberg; A M W J Schols
Journal:  Thorax       Date:  2005-07-29       Impact factor: 9.139

5.  Evidence that a higher ATP cost of muscular contraction contributes to the lower mechanical efficiency associated with COPD: preliminary findings.

Authors:  Gwenael Layec; Luke J Haseler; Jan Hoff; Russell S Richardson
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-02-09       Impact factor: 3.619

6.  The effect of higher ATP cost of contraction on the metabolic response to graded exercise in patients with chronic obstructive pulmonary disease.

Authors:  Gwenael Layec; Luke J Haseler; Russell S Richardson
Journal:  J Appl Physiol (1985)       Date:  2011-12-15

Review 7.  New modalities of pulmonary rehabilitation in patients with chronic obstructive pulmonary disease.

Authors:  Martijn A Spruit; Emiel F M Wouters
Journal:  Sports Med       Date:  2007       Impact factor: 11.136

8.  Bronchodilation improves endurance but not muscular efficiency in chronic obstructive pulmonary disease.

Authors:  Hester van der Vaart; Dirkje S Postma; René Grevink; Willem Roemer; Nick ten Hacken
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2011-04-08

9.  Brown adipose tissue activation is not related to hypermetabolism in emphysematous chronic obstructive pulmonary disease patients.

Authors:  Karin J C Sanders; Roel Wierts; Wouter D van Marken Lichtenbelt; Judith de Vos-Geelen; Guy Plasqui; Marco C J M Kelders; Vera B Schrauwen-Hinderling; Jan Bucerius; Anne-Marie C Dingemans; Felix M Mottaghy; Annemie M W J Schols
Journal:  J Cachexia Sarcopenia Muscle       Date:  2022-02-15       Impact factor: 12.910

10.  Validity of six activity monitors in chronic obstructive pulmonary disease: a comparison with indirect calorimetry.

Authors:  Hans Van Remoortel; Yogini Raste; Zafeiris Louvaris; Santiago Giavedoni; Chris Burtin; Daniel Langer; Frederick Wilson; Roberto Rabinovich; Ioannis Vogiatzis; Nicholas S Hopkinson; Thierry Troosters
Journal:  PLoS One       Date:  2012-06-20       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.